Skip to main content
Clinical Trials/NCT01201148
NCT01201148CompletedPhase 2

A Study of Transcranial Electrical Stimulation (TES) for the Treatment of Depression

The University of New South Wales2 sites in 1 country7 target enrollmentStarted: September 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
7
Locations
2
Primary Endpoint
Montgomery Asberg Depression Rating Scale for Depression (MADRS)

Study Overview

Brief Summary

This study will investigate whether using oscillating TES (random noise stimulation) or intermittent tDCS will have greater antidepressant effects in depressed subjects, compared to standard tDCS.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject meets criteria for a DSM-IV Major Depressive episode.

Exclusion Criteria

  • Diagnosis (as defined by DSM-IV) of: any psychotic disorder (lifetime); bipolar disorder; eating disorder (current or within the past year); obsessive compulsive disorder (lifetime); post-traumatic stress disorder (current or within the past year); mental retardation.
  • Subject has not responded adequately to standard tDCS or is not appropriate for trial of standard tDCS (eg depression too chronic in duration)
  • Total MADRS depression score of 20 or more
  • History of drug or alcohol abuse or dependence (as per DSM-IV criteria) within the last 3 months (except nicotine and caffeine).
  • Inadequate response to ECT in the current episode of depression.
  • Subject is on regular benzodiazepine medication which it is not clinically appropriate to discontinue.
  • Subject requires a rapid clinical response due to inanition, psychosis or high suicide risk.
  • Neurological disorder or insult, e.g., recent stroke (CVA), which places subject at risk of seizure or neuronal damage with TES.
  • Subject has metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
  • Female subject who is pregnant. However, women of child bearing age are eligible if they have the pregnancy test but will be excluded if they are sexually active and not using reliable contraception (urine test for pregnancy will be used if appropriate).

Outcomes

Primary Outcomes

Montgomery Asberg Depression Rating Scale for Depression (MADRS)

Time Frame: 6 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Colleen Loo

Professor

The University of New South Wales

Study Sites (2)

Loading locations...

Similar Trials

Open Pilot Trial of TES for Depression | Clinical Trial